Baxter International is recalling a single lot of Dianeal PD-2 peritoneal dialysis solution with 1.5% dextrose 6000 mL (Ambu-Flex II) because of complaints of particulate matter, identified as mold, ...

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) today announced completion of CE marking (market approval) in Europe for HOMECHOICE CLARIA, an automated peritoneal dialysis (APD ...

Baxter International Inc. BAX recently announced the enrollment of the first group of patients under a U.S. clinical trial for the company’s flagship peritoneal dialysis (PD) solution generation ...

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global innovator in renal care, announced the Sharesource remote patient management platform has performed more than 5 million ...

Baxter International Inc. (NYSE:BAX), a global innovator in renal care, announced today new data associating the use of its automated peritoneal dialysis (APD) cyclers and the Sharesource remote ...

The US Food and Drug Administration (FDA) has cleared Baxter International's AMIA automated home peritoneal dialysis (APD) system with remote connectivity over the Internet, using the company's ...

With no immediate resolution in sight, Baxter Healthcare is relying on help from competitor Fresenius Medical Care to meet a shortage of exchange fluid for new patients on peritoneal dialysis, while ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Baxter International Inc. is developing a ...

Baxter International Inc. BAX recently launched Sharesource 2.0 clinical portal to improve peritoneal dialysis (“PD”) treatment at home. Sharesource 2.0 is a remote patient management platform, ...

Baxter Healthcare Corporation announced today that the U.S. Food and Drug Administration (FDA) has classified Baxter’s recent Urgent Product Recall regarding Increased Intraperitoneal Volume (IIPV), ...

NEW YORK -- Health care giant Baxter International said Tuesday it would buy Gambro for $4 billion, a privately held Swedish dialysis products maker. "Baxter has a legacy of innovation in dialysis, ...